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ARACHIDONIC acid (AA), a fatty acid found in the human
bone marrow plasma, is the precursor of eicosanoids
that modulate bone marrow haematopoiesis. To fur-
ther our understanding of the role of AA in the bone
marrow physiology, we have assessed its incorpora-
tion in human bone marrow mononuclear cells. Gas
chromatography analysis indicates  the presence  of
AA in their fatty acid composition. In bone marrow
mononuclear cells,  [3H]-AA is  incorporated into  tri-
glycerides and is later delivered into phospholipids, a
result  not  observed with  blood  mononuclear cells.
Prelabelling-chase experiments indicate a trafficking
of labelled AA from phosphatidylcholine to phospha-
tidylethanolamine.  Stimulation  of  prelabelled  bone
marrow mononuclear cells with granulocyte-macro-
phage colony-stimulating factor (GM-CSF) results in
the release of a part of the incorporated labelled AA.
Finally, exogenous AA (up to 1 m M) has no significant
effect  on  cell  growth.  In  conclusion,  human  bone
marrow mononuclear cells participate to the control
of marrow AA concentrations  by  incorporating AA
into phospholipids and triglycerides. In turn, bone
marrow  mononuclear  cells  can  release  AA  in
response to the potent haematopoietic growth factor
GM-CSF.
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Introduction
Arachidonic acid (AA), a 20-carbon polyunsaturated
fatty acid, is converted to prostaglandins through the
cyclooxygenase  pathway  or to  hydroxyeicosatetrae-
noic  acid  (HETE)  and  to  leukotrienes  through  the
lipoxygenase pathway.1 Several AA metabolites mod-
ulate human haematopoiesis by acting on the growth
of  human  bone  marrow  erythroid  and  myeloid
progenitors,2–5 and on the cytokine  production by
human bone marrow stromal cells.6 The role of AA in
the bone marrow physiology is poorly documented.
Recently we have reported the presence of AA in the
human  bone  marrow  plasma  and  its  capture  by
cultured  human  bone  marrow  stromal  cells.7 To
further our understanding  of  the role of AA in  the
bone marrow, the uptake and the distribution of AA
among triglycerides (TG) and phospholipids (PL) in
human bone marrow mononuclear cells were com-
pared  with  those  in  blood  mononuclear  cells  and
erythrocytes. We have also investigated the role of AA
on the proliferation of human bone marrow mono-
nuclear  cells  and  their  capacity  to  release  AA  in
response to granulocyte-macrophage colony stimulat-
ing factor (GM-CSF), a potent haematopoietic growth
factor.
Material and Methods
Reagents
AA  (Tebu,  Le  Perray  en Yvelines,  France)  was  dis-
solved  (0.1M)  in  ethanol  stored  at  –80°C,  and
appropriately  diluted  in  2%  human  serum  albumin
(HSA) from Bio Merieux (France) immediately before
use.  Phosphatidylethanolamine  (PE),  phosphatidyl-
choline (PC), phosphatidylserine (PS), phosphatidyli-
nositol (PI), neutral lipid (NL), bovine serum albumin
(BSA)  and  standard  solutions  of  monoglycerides
(MG), diglycerides (DG), TG and PL were from Sigma
(Saint  Quentin  Fallavier,  France).  Hanks’s  balanced
salts solution (HBSS), RPMI 1640, penicillin, strepto-
mycin  and fetal  calf  serum (FCS)  were from  Gibco
(Cergy Pontoise, France). [3H]-thymidine and [3H]-AA
were from Amersham (Les Ulis, France). GM-CSF was
from R&D systems (Oxon, UK).
Human  bone  marrow  cells  from  patients  under-
going a myelogram as part of a diagnostic procedure
were harvested by aspiration into heparinized tubes
(Vacutainer  system,  Becton  Dickinson,  Meylan,
France). When samples were considered as normal by
morphological analysis of the May Grunwald Giemsa
stained smears, bone marrow mononuclear cells were
isolated by separation on a Ficoll gradient (400 3 g,
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10min) before use. For preparation of blood mono-
nuclear cells, human blood was drawn from healthy
volunteers  using  heparin  as  anticoagulant  and  pre-
pared  as  bone  marrow  cells.  For  preparation  of
erythrocytes, blood was recovered using heparin as
anticoagulant.  The  buffy  coat  was  aspirated  and
discarded. The red cells were washed three times with
HBSS before use.
Fatty acid analysis of human bone marrow
mononuclear cells
Cell  lipids  were  extracted  from  freshly  isolated
mononuclear bone marrow cells according to Floch et
al.8 Fatty acids were then methyl transesterified and
the resulting fatty acid methyl esters were separated
by  gas  chromatography.9 Standards  were  run  to
identify  the  compounds  quantified  by  gas
chromatography.
Incorporation of [
3H]-AA in cells
The incorporation of [3H]-AA was performed with 5
3 106 human bone marrow mononuclear cells, 5 3
106 blood  mononuclear  cells  and  5  3 107 blood
erythrocytes  maintained  in  1ml  of  RPMI  1640
medium without FCS. [3H]-AA (0.1m Ci; 210Ci/mmol)
was added into the  medium  for  various periods of
time.  At  the  end  of  the  experiments,  cells  were
harvested by  centrifugation (800  3 g,  10min)  and
then stored at –20°C until used. For AA remodelling
studies,  mononuclear  bone  marrow  cells  were
labelled with [3H]-AA for  0.5h, washed with HBSS,
and incubated in 1ml of RPMI 1640 without FCS for
2, 5 and 22h or used immediately.
Lipid extraction
Cells were mixed with 1ml of 0.1% sodium dodecyl
sulphate in water, and incubated for 30min at 56°C
with  3ml  of  chloroform/methanol  (2:1,  v/v).  The
chloroformic extract was washed with 5ml of 0.1M
KCl/methanol/chloroform (96:92:6, v/v/v), and was
evaporated.10The dry extract was recovered in 150m l
of chloroform and applied to a thin layer chromatog-
raphy  (TLC)  plate  (Silica  gel  60  (20  3 20cm,
0.25mm),  Merck)  and  submitted to TLC. The  plate
was  developed  in  the  mixture  of  diethyl  ether/
hexane/acetic acid (70:30:1,  v/v/v).  Each  lane  was
divided in areas of 0.5cm length which were scraped
into vials and radioactivity was measured on a Packard
liquid scintillation counter. Solutions of MG, DG, TG,
PL and AA were used as standards and visualized with
iodine vapour.
Analysis of labelled PL
For the separation of the various species of cellular
PL, the corresponding areas were scraped from the
TLC  plates  and  were  extracted  with  chloroform/
methanol (2:1, v/v). Samples were then rechromato-
graphed  using  a  solvent  system  of  chloroform/
methanol/acetic  acid/water  (50:30:8:4,  v/v/v/v).10
Each lane was divided in areas of 0.5cm length and
processed as above. Solutions of PC, PS, PI, and PE
were  used  as  standards and  visualized  with  iodine
vapour. In this chromatography, PI and PS migrated to
the same area.
To ensure that the labelled compound in cellular PL
from freshly-isolated marrow mononuclear cells was
authentic AA,  labelled  PL  were  submitted  to  base
hydrolysis.11 The  labelled  PL  were  resuspended  in
1ml  of 2M KOH  in  ethanol/water  (3:1,  v/v). After
40min  at 60°C, 1ml  of  water and 1ml  of  6N HCl
were added to the mixture to acidify the phase (pH
3). Labelled compounds were extracted with chloro-
form/methanol  (2:1,  v/v)  and  rechromatographed
using a solvent system of diethyl ether/hexane/acetic
acid  (70:30:1,  v/v/v). The  amount  of  radioactivity
migrating  with  PL  and  free AA was  determined by
liquid scintillation counting. In another set of experi-
ments labelled PL were hydrolysed with PLA2 from
bovine pancreas (Sigma). Briefly, labelled PL samples
were resuspended in 1ml of diethyl ether/methanol
(95:5, v/v)  containing 50m l  of Tris buffer  (0.05M),
CaCl2 (25mM), EDTA (1mM), and 1mg of phospholi-
pase. The reaction mixture was incubated at 37°C for
2h  with  continuous  shaking.  After  evaporation  of
solvent, samples were rechromatographed as for base
hydrolysis.
Proliferation studies
Freshly-isolated bone marrow mononuclear cells (1 3
105 per  well)  were  cultured  in  96-well  microtitre
plates in 100m l of RPMI 1640 with 10% FCS in the
presence  of  AA  (from  1m M  to  0.1nM)  or  the
appropriate  vehicle  (10m l  2%  HSA).  After  64h  of
incubation, cultures were pulsed for 8h with 1m Ci/
ml  [3H]thymidine  and cells were harvested using  a
Skatron cell harvester. Each experiment was carried
out  as  sixplicates. In  separate sets  of  experiments,
cells  (in  triplicate  samples)  were  harvested  and
counted  by  using  a  haemocytometer.  Data  were
compared  using  the  Student’s  t-test  for  paired
variables.
Release of AA from [
3H]-labelled bone marrow
mononuclear cells
Freshly-isolated  human  bone  marrow  mononuclear
cells were labelled for 0.5h with [3H]-AA as reported
above. After washing, labelled cells (1 3 106) were
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fatty acid-free BSA, 1mM Ca2+ and 1mM Mg2+. Cells
were  then  incubated  at  37°C  in  the  absence  or
presence of GM-CSF (100ng/ml). After various peri-
ods  of  time  (from  1  to  60min)  the  mixture  was
centrifuged  (5min,  2000  3 g)  and  the
[3H]-supernatant fluid was removed into a separate
vial. Radioactivity in the packed labelled cells and in
the  radioactive  supernatant  fluid  were  then  meas-
ured on a Packard liquid  scintillation counter.
Results
Fatty acid composition of human bone marrow
mononuclear cells
As shown in Table 1, AA is present in freshly isolated
human bone marrow mononuclear cells.
Incorporation of [
3H]-AA in cellular lipid
species
After 5h of incubation with [3H]-AA, freshly-isolated
bone marrow mononuclear cells, blood mononuclear
cells and erythrocytes had incorporated 52%, 49% and
41% of the initially  added radioactivity, respectively
(mean of three experiments). Lipids were extracted
from labelled cells and separated into classes by TLC.
The distribution of label in cell lipids as a function of
time is shown in Fig. 1. A trafficking of labelled AA
from TG  to  PL  was  observed  with  freshly-isolated
human bone marrow mononuclear cells (Fig. 1A) but
not with blood mononuclear cells and erythrocytes
(Fig. 1B and 1C, respectively). For mononuclear bone
marrow  cells  at  24h,  67  ±  8%  of  the  label  was
recovered in PL while 30 ± 7% was recovered in TG.
Less than 3% of label was recovered in DG or as free
AA. Labelled MG were not detected.
Incorporation of [
3H]-AA in cellular PL species
We next investigated the distribution of [3H]-AA into
PL  species  using  mononuclear  bone  marrow  cells
labelled  for  0.5h. The  percentage  (mean  of  three
experiments)  of  incorporated AA  into  PE  (43.7  ±
4.3%) was similar to that for PC (42.0  ± 3.6%) and
higher  than  for  PI  +  PS  (14.1  ±  1.6%).  We  then
investigated  the  putative  exchange  of  labelled  AA
between  PL  species.  Freshly-isolated  bone  marrow
AA and human mononuclear marrow cells
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FIG.1. Time-course of [
3H]-AA incorporation into bone mar-
row mononuclear cells (A), blood mononuclear cells (B) and
erythrocytes  (C).  Cells  were  incubated  with    [
3H]-AA  for
10min, 1, 5, or 24h. Lipids were extracted and separated as
described  in  Methods.  Results  are  expressed  as  the  per-
centage of total radioactivity found in cells. Mean ± SEM of
three independent experiments in duplicate. PL: phospho-
lipids; DG:  diglycerides; TG:  triglycerides; AA:  arachidonic
acid.
Table  1.  Fatty  acid  composition  of  human  bone  marrow
mononuclear cells. Data (mean ± SEM of four independent
samples)  are  reported  as  the  percentage  of  fatty  acid
species
Major fatty acids Percentage
C14:0 1.6 ± 0.2
C16:0 19.4 ± 1.0
C16:1 3.0 ± 0.5
C18:0 14.4 ± 6.3
C18:1 28.3 ± 4.4
C18:2 12.3 ± 2.7
C20:4 3.4 ± 0.7
Others* 17.4 ± 5.1
*Others:  includes the sum of all other fatty acids (not  shown) that
were <2% of total fatty acids. C20:4 is arachidonic acid.mononuclear cells labelled for 0.5h were grown in
culture medium free of [3H]-AA for 2, 5 or 22h. Under
these  experimental  conditions,  a  trafficking  of
[3H]-AA from PC to PE was documented (Fig. 2).
Base hydrolysis of labelled PL from bone marrow
mononuclear cells resulted in the loss of 99% (mean
of  three  experiments)  of  radioactivity,  which  was
recovered as  free  fatty  acid.  Similarly,  treatment of
labelled PL with PLA2 from bovine pancreas lead to
the loss of 80% (mean of two experiments) of label.
Release of [
3H]-AA by bone marrow
mononuclear cells
Prelabelled human bone marrow mononuclear cells
were challenged with GM-CSF (100ng/ml) for various
periods  of  time.  As  reported  in  Fig.  3,  GM-CSF
stimulated  in  a  time-dependent  manner  [3H]-AA
release by human bone marrow mononuclear cells.
Their amounts of [3H]-AA released in response to 1h
of stimulation with GM-CSF represented 11.4 ± 2.9%
(mean ± SEM of three independent experiments) of
their total [3H]-AA content.
Effect of AA on the growth of human bone
marrow mononuclear cells
As reported in Table 2, the addition of AA (1m M to
1nM)  had  no  significant  (P >  0.1)  effect  on  the
[3H]-thymidine  incorporation  by  freshly-isolated
human  bone  marrow  mononuclear  cells  cultured
with 10%  FCS  in  medium.  No significant  (P =  0.5,
Mann-Whitney U-test, three experiments) effect of AA
(1m M)  was  found  after  3  days  of  growth  on  the
number of viable mononuclear marrow cells (87.4 ±
10.4 3 103 cells) compared with controls (88.5 ± 13.7
3 103 cells).
Discussion
AA metabolism plays a pivotal role in many cellular
functions,1 and AA metabolites act on human marrow
haematopoiesis in vitro.2–5 Recently we have repor-
ted the presence of AA in the human bone marrow
plasma.7 To further our understanding of the role of
AA in the human bone marrow, we have investigated
the  capacity of  human  bone  marrow  mononuclear
cells  to  capture  and  to  release AA  as  well  as  the
putative role of AA in their growth.
Using gas chromatography analysis, we found that
AA is present in freshly-isolated human bone marrow
mononuclear  cells.  Similarly  to  what  was  observed
with  human  bone  marrow  stromal  cell  cultures,7
experiments  with  [3H]-AA  indicate  that  freshly-iso-
lated bone marrow mononuclear cells incorporate AA
into  PL  and TG. Time-course  experiments  reveal  a
transfer of AA from TG to PL. As already shown in
several inflammatory cell types, the incorporation of
AA into TG is important to capture fatty acids for PL
biosynthesis but also to regulate AA metabolism.12,13
In  contrast to bone marrow mononuclear cells,  no
transfer of AA from TG to PL is observed with blood
mononuclear cells. As previously reported for various
kinds  of  mammalian  erythrocytes,14,15 human  ery-
throcytes incorporate exogenous AA into PL and TG.
Their lack of transfer of AA from TG to PL might be
related to their inability of de novo PL synthesis.12
The analysis of PL species of human bone marrow
mononuclear cells indicates a preferential incorpora-
tion  of AA  into  PE  and  PC.  Similarly  to  what  was
observed  in  several  inflammatory  cell  types,12,16
prelabelling-chase experiments indicate a trafficking
Y. Denizot et al.
34 Mediators of Inflammation · Vol 8 · 1999
FIG.2. Trafficking of [
3H]-AA into PL species of bone marrow
mononuclear  cells.  Cells  were  labelled  for  0.5h  with
[
3H]-AA.  Medium  was  removed  and  cells  were  incubated
with medium free of  [
3H]-AA  for  2, 5 or  22h. Results  are
expressed as the percentage of total radioactivity found in
PL species. Mean ± SEM of three independent experiments
in  duplicate.  PC:  phosphatidylcholine;  PE:  phosphatidyle-
thanolamine;  PI  +  PS:  phosphatidylinositol  +  phosphati-
dylserine (comigration).
FIG. 3.  Release  of  [
3H]-AA  by  bone  marrow  mononuclear
cells. Labelled cells were stimulated with GM-CSF (100ng/
ml) at 37°C for various periods of time. Radioactivity in cell
supernatants was measured on a liquid scintillation counter.
Mean ± SEM of three independent experiments. *P < 0.05
compared with controls (Mann-Whitney U-test).of labelled AA from PC to PE. At this time the meaning
of  this  traffic  is  unclear.  PLA2-treatment  and  base
hydrolysis experiments confirm that [3H]-AA is incor-
porated unmodified in mononuclear bone marrow PL
and  is  linked  by  an  ester  bond.  Stimulation  of
prelabelled bone marrow mononuclear cells with GM-
CSF  results  in  the  hydrolysis  of  a  part  of  the
incorporated labelled AA. This effect might be medi-
ated through the activation of a cellular phospholipase
A2 (PLA2) activity. Strenghtening this hypothesis GM-
CSF generates PLA2 activity with the release of free
fatty acids from neutrophil plasma membranes.17
Exogenous
AA  does  not  change  the  growth  of  human  bone
marrow mononuclear cells assessed by [3H]-thymidine
incorporation into DNA and cell  counts.  In  similar
experimental conditions several lipoxygenase metabo-
lites  of AA  have  no  effect  on  their  growth.18 As  a
positive control of cell stimulation we may mention
that  in  similar  experimental  conditions,  the  lipid
mediator  platelet-activating  factor  (PAF)  stimulates
their [3H]-thymidine incorporation.19
In conclusion human bone marrow mononuclear
cells might participate to the control of marrow AA
concentrations by incorporating AA into their PL and
TG. In turn, the potent haematopoietic growth factor
GM-CSF  stimulates  their  AA  release,  a  result  of
importance considering the role of eicosanoids dur-
ing human marrow haematopoiesis.2
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